Taro Pharmaceutical Industries Ltd.
(NYSE : TARO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-0.15%139.822.8%$270.13m
ZTSZoetis, Inc. Class A
0.77%98.731.9%$176.35m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
1.83%14.482.0%$161.80m
MYLMylan N.V.
0.56%26.883.2%$123.97m
TXMDTherapeuticsMD, Inc.
1.19%4.2525.3%$9.16m
TAROTaro Pharmaceutical Industries Ltd.
1.01%103.876.4%$7.82m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
0.94%40.622.0%$7.30m
JAGXJaguar Animal Health, Inc.
-3.58%0.249.8%$3.58m
ABEOAbeona Therapeutics, Inc.
-2.32%7.997.8%$2.87m
KINKindred Biosciences, Inc.
0.00%8.680.3%$1.89m
LFVNLifeVantage Corporation
-0.05%11.053.3%$1.22m
PETXAratana Therapeutics, Inc.
-0.85%3.508.5%$0.92m
CPHIChina Pharma Holdings, Inc.
0.14%0.360.1%$0.55m

Company Profile

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.